In vivo and in vitro characterization of GL0034, a novel long-acting glucagon-like peptide-1 receptor agonist. (2022)

First Author: Jones B
Attributed to:  Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/dom.14794

PubMed Identifier: 35676825

Publication URI: http://europepmc.org/abstract/MED/35676825

Type: Journal Article/Review

Volume: 24

Parent Publication: Diabetes, obesity & metabolism

Issue: 11

ISSN: 1462-8902